From workforce intelligence to workforce development: advancing the Eastern Mediterranean pharmaceutical workforce for better health outcomes by Bader, L et al.
Report
899
EMHJ – Vol. 24 No. 9 – 2018
From workforce intelligence to workforce development: advancing 
the Eastern Mediterranean pharmaceutical workforce for better 
health outcomes
Lina Bader 1, Ian Bates 2 and Chris John 3
1FIP Education, International Pharmaceutical Federation, The Netherlands (Correspondence to: L.R. Bader: lina@fip.org). 2School of Pharmacy, Univer-
sity College London, United Kingdom. 3Royal Pharmaceutical Society, United Kingdom.
Introduction
A report commissioned by the Global Health Workforce 
Alliance and World Health Organization (WHO) for the 
3rd Global Human Resources Forum (Recife, Brazil 2013) 
states that there is no health without a workforce (1). 
However, it is equally axiomatic that there is no health 
workforce without workforce intelligence; effective hu-
man resources for health planning are reliant on under-
standing the state of health workforce quality, accessibil-
ity, acceptability and availability at a national level (and 
increasingly transnational comparisons, particularly in 
relation to workforce migration and mobility) (2,3). Work-
force intelligence provides strategic workforce informa-
tion to support workforce planning and increased capac-
ity. Strengthening data on human resources for health is 
a priority for WHO as demonstrated by the recent launch 
of the National Health Workforce Accounts (4). This links 
to other objectives focused on policy development and 
investment in human resources for health aligned with 
population health needs (5). Other WHO guidelines rec-
ommend governance and planning, including national 
plans to produce and retain graduates in the health work-
force informed by needs and intelligence in the labour 
market (6).
Achieving universal health coverage by 2030, as part 
of the Sustainable Development Goals (SDGs), depends 
on access to quality essential health services, and safe 
and effective use of drugs and vaccines (7). Health 
workforce, health service delivery and access to essential 
drugs are three of the six health system building blocks 
of the WHO (8). The pharmaceutical workforce plays 
an integral role in bettering health outcomes through 
optimizing effective choice and responsible use of drugs 
(9). Pharmaceutical workforce refers to the whole of the 
pharmacy-related workforce (e.g., registered pharmacist 
practitioners, pharmaceutical scientists, pharmacy 
technicians and other pharmacy support workforce 
cadres, and pre-service students/trainees) working in a 
diversity of settings (e.g., community, hospital, research 
and development, industry, military, regulatory and 
academia) with a diversity of scope of practice. In many 
countries, pharmacists are the most accessible of all 
healthcare workers, and as such, are at the forefront 
of healthcare service delivery (10). Investment in the 
development of a flexible, adaptable, well-distributed and 
competent pharmaceutical workforce contributes 
towards strengthening health systems and achieving 
universal health coverage and the SDGs. This partly 
explains why pharmacists have been recognized in the 
indicator selected by the United Nations (UN) to follow 
up on the achievement of SDG 3: “Ensure healthy lives 
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and promote well-being for all at all ages”, specifically 
target 3.c that focuses on the health workforce (11). In 
addition to physicians, nursing personnel, midwifery 
personnel and dentists, the indicator includes the density 
of pharmacists per population (12).
Health workforce planning in the WHO Eastern 
Mediterranean Region remains underdeveloped and 
sufficient evidence to inform health sector reform is 
lacking. In the low- and middle-income countries of the 
Region, as in other regions of the world, human resources 
for health systems typically suffer from poor planning 
and management, geographic and sectoral distribution 
imbalances, limited educational and training capacities, 
workforce shortages and underemployment, and a lack 
of workforce intelligence required to inform needs-based 
planning (13,14). As a result of these persistent challenges, 
researchers have urgently called for the generation of 
research on the health workforce in the Region (13), and 
priority areas for research include improving planning 
and management and the development of minimum 
databases (14). Despite this, human resources for health 
literature on health workers in the Region remain 
scarce, and where literature is retrieved, it is primarily 
concentrated on the medical and nursing professions 
(13,15). Markedly less is reported about pharmacy 
workforce issues in the Region (16).
Global and regional pharmacy 
workforce trends
While research into pharmaceutical human resourc-
es and pharmacy workforce issues has been garnering 
more global attention in recent years (17,18), considerably 
more is published about other health professionals (19). A 
systematic review of 69 papers published between 1998 
and 2008 identified several global trends affecting the 
pharmacy workforce, including increased feminization 
and overall distribution imbalances (20). In addition to 
calling for a “more coordinated monitoring and model-
ling of the pharmacy workforce worldwide”, the review 
also distinctly found that “there were significant short-
falls of published information regarding the pharmacist 
workforce in developing nations” compared to more de-
veloped countries.
Systematic efforts to address this knowledge gap and 
build a global evidence base on the pharmacy workforce 
and its issues are being led by the International 
Pharmaceutical Federation (FIP). FIP is the global 
professional leadership body representing > 4 million 
pharmacists and pharmaceutical scientists around the 
world. FIP has collated global pharmaceutical workforce 
data since 2006, and global reports on the pharmacy 
workforce were published in 2006, 2009 and 2012, based 
on survey data collected from 34, 56 and 90 countries 
and territories, respectively (21–23). The 2006 Global 
Pharmacy Workforce and Migration Report was the first 
to highlight issues and trends affecting the pharmacy 
workforce globally. In this report, a call for action is 
directed to pharmacy regulators and policy-makers in 
order to strengthen strategic planning and workforce data 
systems (21). The 2009 FIP Global Pharmacy Workforce 
Report strongly recommended that pharmacy workforce 
planning be integrated into the broader national health 
workforce planning (22). The 2012 FIP Global Pharmacy 
Workforce Report stressed the importance of a needs-
based approach in the development of a locally relevant 
workforce plan (23).
Analysis of data from 2006, 2009 and 2012 enabled 
trends to be monitored over the 2006–2012 period. These 
6-year trends are reported in the 2015 FIP report, Global 
Pharmacy Workforce: Intelligence Trends (24). The report 
is the first publication of its kind to provide a baseline 
on the current growing global trend, regarding capacity 
building and pharmacist numbers. Matching data 
across the 3 time points provided an overview of mean 
percentage change in pharmacist capacity (capacity is 
measured as density: the number of pharmacists per 
10 000 population). All WHO regions have experienced 
an increase in the density of pharmacists over the 
period 2006–2012 (Table 1). Countries in the Eastern 
Mediterranean Region showed large proportional 
changes in the pharmacist workforce. The mean 
pharmacist density in the Region increased markedly 
by 38.5% between 2006 and 2012, recording the highest 
increase after the Western Pacific Region (43.1%). 
The analysis was based on 5 countries in the Eastern 
Mediterranean Region that submitted data to FIP at 
all data collection points (2006, 2009 and 2012) (24). In 
terms of rate of increase in the same period, the Eastern 
Mediterranean displayed the highest proportional 
change in capacity among all WHO regions.  
The relatively high production of pharmacists in the 
Eastern Mediterranean Region can be partly explained 
by the regional education capacity. The FIP 2013 Global 
Education Report analysed global pharmacy-graduate 
production capacity trends (measured as the mean 
number of graduates per 10 000 population) and found 
strong correlations between total workforce capacity 
and the annual graduating cohort (R2 = 0.57, P < 0.0001) 
(25). Eleven of 22 countries in the Eastern Mediterranean 
Region were included in the analysis, and results show 
that the Region exhibited the second highest production 
capacity in the world, with the Western Pacific Region 
demonstrating the highest production and the African 
Region the lowest. The mean number of graduates per 
10 000 population was 0.46 in the Eastern Mediterranean 
Table 1 Mean change in pharmacist density 2006–2012
WHO Region Mean change in pharmacist 
density 2006–2012 (%)
Africa 14.8
Eastern Mediterranean 38.5
Europe 24.2
Americas 14.3
South East Asia 24.1
Western Pacific 43.1
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Region, compared to the total sample mean (n = 109) of 
0.36. The report also lists Egypt and Jordan among the 
countries with the highest graduate production capacity 
in the world, at 1.46 and 1.20 graduates per 10 000 
population, respectively. While the state of the pharmacy 
workforce varies among the countries in the Eastern 
Mediterranean Region (26), an increase in the number of 
pharmacy schools is well documented, with some schools 
having a positive impact on practice advancement and 
playing a significant role in supplying pharmacists to 
neighbouring countries (27).
Workforce intelligence for workforce 
development
FIP has developed a transformative workforce roadmap 
adopted at the Global Conference on Pharmacy and Phar-
maceutical Sciences Education held in Nanjing, China, 
on 7 and 8 November 2016 (28). The workforce roadmap 
sets out the desired milestones for education and work-
force development of pharmacists and pharmaceutical 
scientists, clearly linked with a global vision for trans-
forming education for pharmacy and pharmaceutical 
sciences. The Pharmaceutical Workforce Development 
Goals (PWDGs) have been developed as a measurable, 
feasible and tangible means to facilitate action-oriented 
workforce planning and ways of monitoring progress 
towards global achievement of the workforce vision (29). 
They aim to provide a consistent structure for coherent 
and comprehensive national workforce development ac-
tions.
There are 13 PWDGs, gathered into 3 groups: 1) 
academy: focus on schools, universities and education 
providers; 2) professional development: focus on the 
pharmaceutical workforce; and 3) systems: focus on policy 
development, governmental strategy and planning, and 
monitoring systems. The PWDGs are aligned with: UN 
High-Level Commission on Health Employment and 
Economic Growth Recommendations and Immediate 
Actions (5); WHO Global Strategy on Human Resources 
for Health Objectives, Milestones and Policy Options (2); 
and International Labour Organization, Organization for 
Economic Co-operation and Development and WHO Five-
Year Action Plan for Health Employment and Inclusive 
Economic Growth (2017–2021) (30).
Workforce intelligence is one of FIP’s transformative 
global PWDGs. PWDG 12 Workforce Intelligence states 
that all countries and territories should have a national 
strategy and corresponding actions to collate and share 
workforce data and workforce planning activities (skill 
mix, advanced and specialist practice, and capacity). The 
development of national monitoring systems can identify 
workforce trends, which in turn enables decision making 
on deployment and supply of pharmaceutical workforce. 
Ideally, this should be linked with stewardship and 
leadership for professional leadership bodies. Country 
case studies demonstrate that leadership bodies play a 
significant role in progressing workforce intelligence 
strategies that are aligned with national and global health 
workforce tracer indicators (31).
Recent research on the pharmacy workforce in the 
Eastern Mediterranean Region reported a disconnect 
between the education, regulation and practice sectors, 
as well as insufficient engagement of professional 
organizations and leadership bodies (27,32). A recent 
in-depth study on Jordan found local deficiencies in 
workforce planning and intelligence that are linked to 
both suboptimal levels of cross-stakeholder engagement 
and the lack of national workforce planning strategies 
– especially important during a witnessed surge in the 
number of pharmacy schools (32). The lack of health 
workforce planning strategies in a climate of increased 
production and capacity may have serious implications 
on the utilization of a health workforce within national 
health systems. In the case of pharmacy in the Region, 
the increased production of pharmacists without 
adequate workforce planning strategies, coupled with 
the lack of effective regulation and clear role descriptions 
in affecting both private and public sectors, should raise 
the concern of policy-makers.
Using workforce intelligence to develop strategic 
workforce strategies relies on purposeful planning that is 
linked with labour market needs and dynamics, as well as 
the production capacity and infrastructure to educate and 
train. The FIP PWDG on workforce intelligence therefore 
links closely to other goals such as PWDG 1: Academic 
Capacity (to support supply-side workforce development 
agendas); PWDG 13: Workforce Policy Formation 
(strategies to implement needs-based workforce 
development) and PWDG 11: Workforce Impact (evidence 
of the impact of the workforce on patient outcomes).
Conclusion
Using evidence generated from this work, countries and 
territories in the Eastern Mediterranean Region can iden-
tify policy gaps and prioritize the development of work-
force planning strategies. They can also learn from other 
country case studies and adopt approaches and methods 
based on their needs. It is important to assess trends in 
the pharmacist workforce against national populations, 
disease burdens and economic situations. The global 
pharmaceutical workforce will continue to be monitored 
and assessed in order to shape workforce development 
and capacity, thereby realizing the PWDGs. Further work 
is also needed to develop professional, economic and 
disease indicators to describe the impact of the pharma-
ceutical workforce, mainly (though not exclusively) fol-
lowing investment of resources by national economies. 
Without workforce intelligence data there can be no stra-
tegic workforce development.
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De l’information sur les personnels au développement des personnels : faire 
progresser les personnels œuvrant dans le secteur pharmaceutique en Méditerranée 
orientale pour de meilleurs résultats sanitaires 
Résumé
Contexte : L’utilisation responsable des médicaments et l’optimisation de l’efficacité au niveau des choix et de 
l’utilisation font des personnels œuvrant dans le domaine pharmaceutique dans la Région de la Méditerranée orientale 
des facteurs clé dans l’amélioration des résultats sanitaires. C’est pourquoi, il est fondamental d’investir dans le 
développement et la planification de ces personnels si l’on veut réaliser la couverture sanitaire universelle.
Objectifs  : Donner un aperçu des tendances au regard des capacités des personnels œuvrant dans le secteur 
pharmaceutique dans la Région de Méditerranée orientale et mettre l’accent sur l’importance des informations 
concernant  les personnels en vue d’un développement stratégique.
Méthodes : Une analyse de la littérature et des études mondiales sur les personnels du secteur pharmaceutique a été 
menée par la Fédération internationale du secteur pharmaceutique afin d’identifier les tendances et les enjeux dans la 
Région de Méditerranée orientale.
Résultats : La Région de la Méditerranée orientale a de fortes capacités de production de personnels par rapport à d’autres 
Régions de l’OMS, mais des problèmes concernant les stratégies de planification de ces personnels et d’information à leur 
égard persistent. Une planification efficace des personnels ne dépend pas seulement de la qualité des informations. Elle 
exige également une coordination et une gestion intersectorielles, et les objectifs de développement pour les personnels 
de santé fournissent un cadre de développement pour les pays de la Région. 
Conclusion : On ne saurait parler de développement des personnels si l’on ne dispose pas d’informations à ce sujet.
 نم طسوتلما قشر ميلقإ في ةينلاديصلا ةلماعلا ىوقلا ينستح :اهريوطت لىإ ةلماعلا ىوقلا لوح تامولعلما عيمتج نم
لضفأ ةيحص تاجرمخ لجأ
نوج سيرك ،ستيب نايإ ،ردب ةنيل
ةصلالخا
 ،ةيودلأل لوؤسلما مادختسلاا للاخ نم ةيحصلا تاجرخلما ينستح في ايسيئر ًارود طسوتلما قشر ميلقإ في ةينلاديصلا ةلماعلا ىوقلا يدؤت :ةيفللخا
 ةيطغتلا قيقحتل سياسأ رمأ ةلماعلا ىوقلا ريوطت في رماثتسلااو طيطختلا نإف ،اذكهو . ةينلاديصلا تاضرحتسلما مادختساو رايتخا ةيلاعف ينستحو
.ةلماشلا ةيحصلا
 عيمتج  ةيهمأ  لىع  د ِّكؤتو  ،طسوتلما  قشر  ميلقإ  في  ةينلاديصلا  ةلماعلا  ىوقلا  تاردق  في  تاهاتجلاا  نع  ةماع  ةحلم  ةعجارلما  هذه  مدقت  :فادهلأا
.اله يجيتاترسلاا ريوطتلا لجأ نم ةلماعلا ىوقلا لوح تامولعلما
 ديدحتل لماعلا في ةينلاديصلا ةلماعلا ىوقلا لوح تاساردللو تاروشنملل ةعجارم ينينلاديصلا ينلماعلل ةيلودلا تاداتحلاا ترجأ :ثحبلا قرط
.طسوتلما قشر ميلقإب ةصالخا لئاسلماو تاهاتجلاا
 تايجيتاترسا نكلو ،ةيلماعلا ةحصلا ةمظنلم ىرخلأا ميلاقلأاب ةنراقم اهجاتنإو ةلماعلا ىوقلا نم ةيلاع تاردق طسوتلما قشر ميلقإ ىدل :جئاتنلا
 متي يتلا تامولعلما ةدوج لىع ةلماعلا ىوقلل لاعفلا طيطختلا دماتعا صرتقي لا .ةرمتسم تلاز ام ةلماعلا ىوقلا لوح تامولعلما عيمتجو طيطختلا
 اًراطإ ميلقلإل ةينلاديصلا ةلماعلا ىوقلا ريوطت فادهأ مدقتو ،تاعاطقلا لماك لىع فاشرلإاو لماشلا قيسنتلا لىع اًضيأ دمتعي هنكلو ،اهعيمتج
 .ريوطتلل
.الهوح تامولعلما عيمتج نود ةلماعلا ىوقلل ريوطت كانه سيل :تاجاتنتسلاا
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